US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

34.60

-0.5700-1.62%

Post-market: 35.500.9000+2.60%19:32 EDT

Volume:1.27M

Turnover:44.07M

Market Cap:3.33B

PE:-6.27

High:35.38

Open:34.99

Low:34.36

Close:35.17

52wk High:53.47

52wk Low:25.81

Shares:96.37M

Float Shares:92.79M

Volume Ratio:0.99

T/O Rate:1.37%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.5219

EPS(LYR):-6.2867

ROE:-180.44%

ROA:-21.59%

PB:22.04

PE(LYR):-5.50

Loading ...

Overview Company News Filings

Ultragenyx Pharma Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Ultragenyx Pharmaceutical Reports Positive Phase 3 Data on Rare Metabolic Disorder Treatment

MT Newswires Live

Ultragenyx Announces Promising Phase 3 Results for DTX401 Gene Therapy in Treating Glycogen Storage Disease Type Ia

Ultragenyx Announces Positive Longer-Term Data From Phase 3 Study of Dtx401 Aav Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (Gsdia)

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Dtx401 Was Well Tolerated With an Acceptable Safety Profile

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Study Met Primary Endpoint With 41% Cornstarch Reduction

THOMSON REUTERS

Ultragenyx SVP Theodore Huizenga Reports Disposal of Common Shares

Ultragenyx Pharma Price Target Maintained With a $105.00/Share by Cantor Fitzgerald

Ultragenyx Pharmaceutical Inc. to Participate in Cantor Global Healthcare Conference Fireside Chat

BRIEF-Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Ultragenyx Pharmaceutical Announces Grant of 113,572 Restricted Stock Units to New Employees Under Inducement Plan

Ultragenyx Initiates Rolling Submission of BLA to FDA for DTX401 Gene Therapy for Glycogen Storage Disease Type Ia

Ultragenyx Pharmaceutical Inc - Plans to Complete Full Bla Submission in Q4 2025

THOMSON REUTERS

Ultragenyx Initiates Rolling Submission of Biologics License Application (Bla) to U.S. FDA for Dtx401 Aav Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (Gsdia)

THOMSON REUTERS

Ultragenyx Pharma Is Maintained at Buy by Canaccord Genuity

Stock Track | Ultragenyx Pharmaceutical Plummets 5% as Leerink Partners Slashes Price Target

Earnings Flash: (RARE) Ultragenyx Pharmaceutical Q2 Revenue $166.5 million Vs. FactSet Est. $162 Million

MT Newswires Live

Ultragenyx Reports Q2 2025 Results: Revenue Up 20%, Net Loss Narrows to $115M, EPS Improves to $(1.17)

Ultragenyx Pharmaceutical Q2 EPS $(1.17) Beats $(1.32) Estimate, Sales $166.50M Beat $162.50M Estimate

BRIEF-Ultragenyx Q2 EPS USD -1.17

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RARE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RARE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","market":"US","secType":"STK","nameCN":"Ultragenyx Pharmaceutical","latestPrice":34.6,"timestamp":1761940800000,"preClose":35.17,"halted":0,"volume":1267731,"hourTrading":{"tag":"盘后","latestPrice":35.5,"preClose":34.6,"latestTime":"19:32 EDT","volume":30793,"amount":1065564.64,"timestamp":1761953579993},"delay":0,"floatShares":92794919,"shares":96371643,"eps":-5.521909,"marketStatus":"Not Yet Opened","change":-0.57,"latestTime":"10-31 16:00:00 EDT","open":34.99,"high":35.38,"low":34.355,"amount":44067128.23053,"amplitude":0.029144,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.521909,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1762160400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":35.17,"preHourTrading":{"tag":"盘前","latestPrice":35.17,"preClose":35.17,"latestTime":"09:18 EDT","volume":1027,"amount":36132.55074,"timestamp":1761916714333},"postHourTrading":{"tag":"盘后","latestPrice":35.5,"preClose":34.6,"latestTime":"19:32 EDT","volume":30793,"amount":1065564.64,"timestamp":1761953579993},"volumeRatio":0.9919126317076389,"impliedVol":0.7269,"impliedVolPercentile":0.816},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","floatShares":92794919,"roa":"-21.59%","roe":"-180.44%","lyrEps":-6.286667,"volumeRatio":0.9919126317076389,"shares":96371643,"dividePrice":0,"high":35.38,"amplitude":0.029144,"preClose":35.17,"low":34.355,"week52Low":25.81,"pbRate":"22.04","psRate":"5.46","week52High":53.47,"institutionHeld":0,"latestPrice":34.6,"eps":-5.521909,"divideRate":0,"volume":1267731,"delay":0,"ttmEps":-5.521909,"open":34.99,"prevYearClose":42.07,"prevWeekClose":33.53,"prevMonthClose":34.6,"prevQuarterClose":30.08,"fiveDayClose":33.53,"twentyDayClose":31.21,"sixtyDayClose":27.83,"earningDate":1762185600000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RARE\",params:#limit:5,,,undefined,":[{"date":"2025-11-04","symbol":"RARE","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":-1.23,"defaultRemindTime":1762290000000,"name":null,"time":"Post Market","dateTimestamp":1762232400000,"actualEps":null},{"market":"US","date":"2025-08-05","symbol":"RARE","fiscalQuarterEnding":"2025/06","expectedEps":-1.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-1.17},{"market":"US","date":"2025-05-06","symbol":"RARE","fiscalQuarterEnding":"2025/03","expectedEps":-1.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-1.57},{"market":"US","date":"2025-02-13","symbol":"RARE","fiscalQuarterEnding":"2024/12","expectedEps":-1.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2025-01-12","symbol":"RARE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736658000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RARE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RARE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.619,"hold":0.0476,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.619,"analysts":21,"updateTime":1748491200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RARE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RARE","date":"2025-10-31","current":-6.265949,"percent":0.559378,"low":-57.721347,"twenty":-16.144099,"median":-6.798969,"eighty":-4.922401,"high":-3.237111,"avg":-11.967236,"sd":11.358038,"marketCap":3383305078},"quantilePoints":[{"date":"2020-11-06","current":-28.752844,"twenty":-30.231689,"median":-15.200985,"eighty":-8.83563,"marketCap":7371079013},{"date":"2020-11-13","current":-30.249581,"twenty":-30.174442,"median":-15.200985,"eighty":-8.83563,"marketCap":7754782641},{"date":"2020-11-20","current":-29.514115,"twenty":-30.01147,"median":-15.200985,"eighty":-8.83563,"marketCap":7566238617},{"date":"2020-11-27","current":-31.591484,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":8098792791},{"date":"2020-12-04","current":-33.168219,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":8503004716},{"date":"2020-12-11","current":-37.402954,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9588621362},{"date":"2020-12-18","current":-43.364099,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":11116820295},{"date":"2020-12-24","current":-44.61052,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":11436352800},{"date":"2020-12-31","current":-35.722995,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9157947117},{"date":"2021-01-08","current":-38.860983,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9962401620},{"date":"2021-01-15","current":-35.604289,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9127515450},{"date":"2021-01-22","current":-36.249434,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9292904945},{"date":"2021-01-29","current":-35.764285,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9168532044},{"date":"2021-02-05","current":-41.8622,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":10731793551},{"date":"2021-02-12","current":-53.920829,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":10059793403},{"date":"2021-02-19","current":-53.160067,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9917861006},{"date":"2021-02-26","current":-50.791655,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9475995995},{"date":"2021-03-05","current":-42.523747,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7933485414},{"date":"2021-03-12","current":-45.556031,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":8499206525},{"date":"2021-03-19","current":-44.759384,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":8350579204},{"date":"2021-03-26","current":-38.985484,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7273365868},{"date":"2021-04-01","current":-40.621841,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7578654420},{"date":"2021-04-09","current":-37.133817,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6927907769},{"date":"2021-04-16","current":-39.014192,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7278721807},{"date":"2021-04-23","current":-39.42687,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7355713438},{"date":"2021-04-30","current":-40.376431,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7532869144},{"date":"2021-05-07","current":-37.945412,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7728797410},{"date":"2021-05-14","current":-36.736115,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7482485435},{"date":"2021-05-21","current":-35.563263,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7243596560},{"date":"2021-05-28","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-04","current":-30.543853,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6221233155},{"date":"2021-06-11","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-18","current":-31.448341,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6405461016},{"date":"2021-06-25","current":-31.087209,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":6331904837},{"date":"2021-07-02","current":-31.213108,"twenty":-30.257731,"median":-15.161272,"eighty":-8.834973,"marketCap":6357548275},{"date":"2021-07-09","current":-30.262236,"twenty":-30.265324,"median":-15.161272,"eighty":-8.834973,"marketCap":6163872832},{"date":"2021-07-16","current":-28.271038,"twenty":-30.233301,"median":-15.161272,"eighty":-8.834973,"marketCap":5758301606},{"date":"2021-07-23","current":-27.406308,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":5582171673},{"date":"2021-07-30","current":-26.44881,"twenty":-29.79768,"median":-15.161272,"eighty":-8.834973,"marketCap":5387146575},{"date":"2021-08-06","current":-17.083279,"twenty":-29.687102,"median":-15.161272,"eighty":-8.834973,"marketCap":6003491310},{"date":"2021-08-13","current":-17.901732,"twenty":-29.496644,"median":-15.161272,"eighty":-8.834973,"marketCap":6291116204},{"date":"2021-08-20","current":-15.473397,"twenty":-29.315394,"median":-15.15171,"eighty":-8.834973,"marketCap":5437738569},{"date":"2021-08-27","current":-18.1353,"twenty":-29.179331,"median":-15.15171,"eighty":-8.834973,"marketCap":6373197837},{"date":"2021-09-03","current":-19.766415,"twenty":-28.984947,"median":-15.15171,"eighty":-8.834973,"marketCap":6946412544},{"date":"2021-09-10","current":-19.629363,"twenty":-28.634625,"median":-15.15171,"eighty":-8.834973,"marketCap":6898248941},{"date":"2021-09-17","current":-18.969196,"twenty":-28.497709,"median":-15.15171,"eighty":-8.834973,"marketCap":6666249616},{"date":"2021-09-24","current":-18.359217,"twenty":-28.236842,"median":-15.15171,"eighty":-8.834973,"marketCap":6451887666},{"date":"2021-10-01","current":-16.948157,"twenty":-28.151413,"median":-15.15171,"eighty":-8.834973,"marketCap":5956006068},{"date":"2021-10-08","current":-15.759084,"twenty":-28.053185,"median":-15.15171,"eighty":-8.834973,"marketCap":5538135938},{"date":"2021-10-15","current":-15.442512,"twenty":-27.812745,"median":-15.15171,"eighty":-8.834973,"marketCap":5426884800},{"date":"2021-10-22","current":-15.098916,"twenty":-27.55852,"median":-15.082382,"eighty":-8.834973,"marketCap":5306136613},{"date":"2021-10-29","current":-16.199195,"twenty":-27.366816,"median":-15.082382,"eighty":-8.834973,"marketCap":5692802155},{"date":"2021-11-05","current":-15.975791,"twenty":-27.236045,"median":-15.082382,"eighty":-8.834973,"marketCap":5680639831},{"date":"2021-11-12","current":-15.43713,"twenty":-27.171258,"median":-15.082382,"eighty":-8.834973,"marketCap":5489103979},{"date":"2021-11-19","current":-15.205181,"twenty":-26.927437,"median":-15.06031,"eighty":-8.834973,"marketCap":5406627687},{"date":"2021-11-26","current":-14.662686,"twenty":-26.731524,"median":-14.936554,"eighty":-8.834973,"marketCap":5213728590},{"date":"2021-12-03","current":-14.570673,"twenty":-26.554402,"median":-14.855697,"eighty":-8.834973,"marketCap":5181010722},{"date":"2021-12-10","current":-14.932975,"twenty":-26.360162,"median":-14.855697,"eighty":-8.834973,"marketCap":5309837327},{"date":"2021-12-17","current":-16.265249,"twenty":-26.205264,"median":-14.855697,"eighty":-8.834973,"marketCap":5783564791},{"date":"2021-12-23","current":-16.244163,"twenty":-25.908959,"median":-14.855697,"eighty":-8.834973,"marketCap":5776066946},{"date":"2021-12-31","current":-16.119562,"twenty":-25.241061,"median":-14.855697,"eighty":-8.834973,"marketCap":5731761500},{"date":"2022-01-07","current":-14.145112,"twenty":-24.735967,"median":-14.855038,"eighty":-8.83563,"marketCap":5029690582},{"date":"2022-01-14","current":-13.811564,"twenty":-24.180303,"median":-14.806289,"eighty":-8.83563,"marketCap":4911088311},{"date":"2022-01-21","current":-12.876097,"twenty":-23.989848,"median":-14.747324,"eighty":-8.83563,"marketCap":4578456653},{"date":"2022-01-28","current":-12.651814,"twenty":-23.661155,"median":-14.661474,"eighty":-8.83563,"marketCap":4498706850},{"date":"2022-02-04","current":-13.154053,"twenty":-23.48091,"median":-14.600648,"eighty":-8.83563,"marketCap":4677291879},{"date":"2022-02-11","current":-10.94589,"twenty":-23.205637,"median":-14.505395,"eighty":-8.83563,"marketCap":4969707824},{"date":"2022-02-18","current":-10.194721,"twenty":-23.125145,"median":-14.35823,"eighty":-8.83563,"marketCap":4628658273},{"date":"2022-02-25","current":-10.307809,"twenty":-22.914219,"median":-14.283419,"eighty":-8.83563,"marketCap":4680003006},{"date":"2022-03-04","current":-9.594133,"twenty":-22.459434,"median":-14.16111,"eighty":-8.83563,"marketCap":4355976111},{"date":"2022-03-11","current":-9.996053,"twenty":-21.586553,"median":-14.118393,"eighty":-8.83563,"marketCap":4538458067},{"date":"2022-03-18","current":-10.663883,"twenty":-21.326675,"median":-14.069914,"eighty":-8.83563,"marketCap":4841669529},{"date":"2022-03-25","current":-10.524816,"twenty":-21.159681,"median":-13.968769,"eighty":-8.83563,"marketCap":4778529385},{"date":"2022-04-01","current":-11.823798,"twenty":-21.003206,"median":-13.863231,"eighty":-8.83563,"marketCap":5368299964},{"date":"2022-04-08","current":-12.514551,"twenty":-20.910296,"median":-13.803148,"eighty":-8.83563,"marketCap":5681919142},{"date":"2022-04-14","current":-13.050955,"twenty":-20.848103,"median":-13.773354,"eighty":-8.83563,"marketCap":5925459699},{"date":"2022-04-22","current":-11.470781,"twenty":-20.717776,"median":-13.670793,"eighty":-8.83563,"marketCap":5208021136},{"date":"2022-04-29","current":-10.878745,"twenty":-20.624785,"median":-13.564241,"eighty":-8.83563,"marketCap":4939222202},{"date":"2022-05-06","current":-8.557526,"twenty":-20.519008,"median":-13.487652,"eighty":-8.833003,"marketCap":4023783190},{"date":"2022-05-13","current":-7.654777,"twenty":-20.519008,"median":-13.402239,"eighty":-8.786823,"marketCap":3599306930},{"date":"2022-05-20","current":-7.220506,"twenty":-20.519008,"median":-13.35812,"eighty":-8.748709,"marketCap":3395110773},{"date":"2022-05-27","current":-7.233891,"twenty":-20.519008,"median":-13.323757,"eighty":-8.718034,"marketCap":3401404490},{"date":"2022-06-03","current":-7.645854,"twenty":-20.519008,"median":-13.277877,"eighty":-8.684283,"marketCap":3595111119},{"date":"2022-06-10","current":-7.418308,"twenty":-20.519008,"median":-13.17025,"eighty":-8.65258,"marketCap":3488117927},{"date":"2022-06-17","current":-7.925453,"twenty":-20.519008,"median":-13.057111,"eighty":-8.633594,"marketCap":3726579878},{"date":"2022-06-24","current":-9.008157,"twenty":-20.52732,"median":-13.025475,"eighty":-8.615488,"marketCap":4235671668},{"date":"2022-07-01","current":-9.317501,"twenty":-20.52732,"median":-12.971944,"eighty":-8.615488,"marketCap":4381126466},{"date":"2022-07-08","current":-9.836545,"twenty":-20.52732,"median":-12.903988,"eighty":-8.615488,"marketCap":4625182832},{"date":"2022-07-15","current":-9.62982,"twenty":-20.52732,"median":-12.867014,"eighty":-8.615488,"marketCap":4527979867},{"date":"2022-07-22","current":-7.657752,"twenty":-20.52732,"median":-12.683542,"eighty":-8.593044,"marketCap":3600705534},{"date":"2022-07-29","current":-7.375537,"twenty":-20.52732,"median":-12.576503,"eighty":-8.565198,"marketCap":3731564327},{"date":"2022-08-05","current":-7.696694,"twenty":-20.52732,"median":-12.447093,"eighty":-8.50432,"marketCap":3894049860},{"date":"2022-08-12","current":-7.138822,"twenty":-20.52732,"median":-12.354843,"eighty":-8.455092,"marketCap":3611801282},{"date":"2022-08-19","current":-6.78721,"twenty":-20.52732,"median":-12.331685,"eighty":-8.434672,"marketCap":3433907638},{"date":"2022-08-26","current":-6.852272,"twenty":-20.52732,"median":-12.331685,"eighty":-8.389678,"marketCap":3466824966},{"date":"2022-09-02","current":-6.61002,"twenty":-20.52732,"median":-12.331685,"eighty":-8.359036,"marketCap":3344260447},{"date":"2022-09-09","current":-6.816281,"twenty":-20.52732,"median":-12.331685,"eighty":-8.331801,"marketCap":3448615380},{"date":"2022-09-16","current":-6.371921,"twenty":-20.52732,"median":-12.331685,"eighty":-8.289414,"marketCap":3223797034},{"date":"2022-09-23","current":-5.744834,"twenty":-20.52732,"median":-12.331685,"eighty":-8.245615,"marketCap":2906530022},{"date":"2022-09-30","current":-5.732376,"twenty":-20.52732,"median":-12.331685,"eighty":-8.208124,"marketCap":2900226703},{"date":"2022-10-07","current":-5.25064,"twenty":-20.52732,"median":-12.331685,"eighty":-8.150659,"marketCap":2656498403},{"date":"2022-10-14","current":-5.130206,"twenty":-20.52732,"median":-12.331685,"eighty":-8.077486,"marketCap":2595566328},{"date":"2022-10-21","current":-5.328161,"twenty":-20.52732,"median":-12.331685,"eighty":-8.010065,"marketCap":2695719049},{"date":"2022-10-28","current":-5.642396,"twenty":-20.52732,"median":-12.331685,"eighty":-7.967887,"marketCap":2854702739},{"date":"2022-11-04","current":-3.646694,"twenty":-20.52732,"median":-12.331685,"eighty":-7.881082,"marketCap":2472626416},{"date":"2022-11-11","current":-3.779038,"twenty":-20.52732,"median":-12.331685,"eighty":-7.854126,"marketCap":2562361653},{"date":"2022-11-18","current":-3.721138,"twenty":-20.52732,"median":-12.331685,"eighty":-7.7969,"marketCap":2523102487},{"date":"2022-11-25","current":-3.693221,"twenty":-20.52732,"median":-12.331685,"eighty":-7.738619,"marketCap":2504173960},{"date":"2022-12-02","current":-4.153323,"twenty":-20.52732,"median":-12.331685,"eighty":-7.69117,"marketCap":2816144121},{"date":"2022-12-09","current":-4.202952,"twenty":-20.52732,"median":-12.331685,"eighty":-7.649461,"marketCap":2849794835},{"date":"2022-12-16","current":-4.717852,"twenty":-20.52732,"median":-12.331685,"eighty":-7.588745,"marketCap":3198920992},{"date":"2022-12-23","current":-4.499692,"twenty":-20.52732,"median":-12.331685,"eighty":-7.55634,"marketCap":3050998062},{"date":"2022-12-30","current":-4.790228,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3247994949},{"date":"2023-01-06","current":-4.824348,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3271129815},{"date":"2023-01-13","current":-4.502794,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3053101231},{"date":"2023-01-20","current":-4.383891,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":2972479729},{"date":"2023-01-27","current":-4.520371,"twenty":-20.52732,"median":-12.331685,"eighty":-7.419224,"marketCap":3065019192},{"date":"2023-02-03","current":-4.728192,"twenty":-20.52732,"median":-12.331685,"eighty":-7.265696,"marketCap":3205931557},{"date":"2023-02-10","current":-4.549321,"twenty":-20.52732,"median":-12.331685,"eighty":-7.228067,"marketCap":3084648776},{"date":"2023-02-17","current":-4.834822,"twenty":-20.52732,"median":-12.331685,"eighty":-7.193971,"marketCap":3420254921},{"date":"2023-02-24","current":-4.342506,"twenty":-20.52732,"median":-12.331685,"eighty":-7.118611,"marketCap":3071980143},{"date":"2023-03-03","current":-4.536058,"twenty":-20.52732,"median":-12.331685,"eighty":-7.091607,"marketCap":3208902687},{"date":"2023-03-10","current":-3.847212,"twenty":-20.52732,"median":-12.331685,"eighty":-7.007538,"marketCap":2721598865},{"date":"2023-03-17","current":-3.824383,"twenty":-20.52732,"median":-12.331685,"eighty":-6.964752,"marketCap":2705449027},{"date":"2023-03-24","current":-3.740015,"twenty":-20.52732,"median":-12.331685,"eighty":-6.882782,"marketCap":2645764841},{"date":"2023-03-31","current":-3.980217,"twenty":-20.519008,"median":-12.327325,"eighty":-6.84769,"marketCap":2815689228},{"date":"2023-04-06","current":-3.845227,"twenty":-20.519008,"median":-12.327325,"eighty":-6.817229,"marketCap":2720194531},{"date":"2023-04-14","current":-3.834309,"twenty":-20.52732,"median":-12.331685,"eighty":-6.790561,"marketCap":2712470696},{"date":"2023-04-21","current":-4.095356,"twenty":-20.52732,"median":-12.331685,"eighty":-6.741883,"marketCap":2897140588},{"date":"2023-04-28","current":-4.242476,"twenty":-20.52732,"median":-12.331685,"eighty":-6.708105,"marketCap":3001216442},{"date":"2023-05-05","current":-4.503028,"twenty":-20.52732,"median":-12.331685,"eighty":-6.653176,"marketCap":3238005775},{"date":"2023-05-12","current":-4.638891,"twenty":-20.543943,"median":-12.127091,"eighty":-6.641982,"marketCap":3335701281},{"date":"2023-05-19","current":-5.014059,"twenty":-20.543943,"median":-12.030107,"eighty":-6.608226,"marketCap":3605474618},{"date":"2023-05-26","current":-4.91559,"twenty":-20.543943,"median":-11.942999,"eighty":-6.574925,"marketCap":3534667968},{"date":"2023-06-02","current":-4.885064,"twenty":-20.543943,"median":-11.851539,"eighty":-6.547631,"marketCap":3512717906},{"date":"2023-06-09","current":-5.079049,"twenty":-20.543943,"median":-11.661746,"eighty":-6.51973,"marketCap":3652207007},{"date":"2023-06-16","current":-4.811212,"twenty":-20.543943,"median":-11.483123,"eighty":-6.479975,"marketCap":3459612919},{"date":"2023-06-21","current":-4.936268,"twenty":-20.510696,"median":-11.421308,"eighty":-6.417082,"marketCap":3549537364},{"date":"2023-06-30","current":-4.593595,"twenty":-20.487227,"median":-11.238841,"eighty":-6.371161,"marketCap":3303130222},{"date":"2023-07-07","current":-4.482325,"twenty":-20.498962,"median":-11.187498,"eighty":-6.365701,"marketCap":3223118708},{"date":"2023-07-21","current":-4.237136,"twenty":-19.951513,"median":-11.097535,"eighty":-6.330057,"marketCap":3046810149},{"date":"2023-07-28","current":-4.134728,"twenty":-19.945557,"median":-11.07773,"eighty":-6.267685,"marketCap":2973171233},{"date":"2023-08-04","current":-4.057384,"twenty":-19.897508,"median":-11.023587,"eighty":-6.244893,"marketCap":2924314645},{"date":"2023-08-11","current":-3.621915,"twenty":-19.755822,"median":-10.996766,"eighty":-6.219342,"marketCap":2610455224},{"date":"2023-08-18","current":-3.463233,"twenty":-19.719512,"median":-10.937719,"eighty":-6.110593,"marketCap":2496086977},{"date":"2023-08-25","current":-3.666544,"twenty":-19.634346,"median":-10.899761,"eighty":-5.986933,"marketCap":2642621293},{"date":"2023-09-01","current":-3.648692,"twenty":-19.538575,"median":-10.863505,"eighty":-5.82457,"marketCap":2629754865},{"date":"2023-09-08","current":-4.080109,"twenty":-19.362208,"median":-10.802755,"eighty":-5.750563,"marketCap":2940693535},{"date":"2023-09-15","current":-3.893658,"twenty":-19.077218,"median":-10.732491,"eighty":-5.672427,"marketCap":2806310846},{"date":"2023-09-22","current":-3.630841,"twenty":-18.981061,"median":-10.679378,"eighty":-5.619716,"marketCap":2616888437},{"date":"2023-09-29","current":-3.488027,"twenty":-18.845186,"median":-10.612101,"eighty":-5.581034,"marketCap":2513957016},{"date":"2023-10-06","current":-3.468192,"twenty":-18.69861,"median":-10.535971,"eighty":-5.490331,"marketCap":2499660985},{"date":"2023-10-13","current":-3.237111,"twenty":-18.632497,"median":-10.521807,"eighty":-5.460417,"marketCap":2333112226},{"date":"2023-10-20","current":-3.7042,"twenty":-18.632497,"median":-10.443907,"eighty":-5.405085,"marketCap":2669761173},{"date":"2023-10-27","current":-3.893405,"twenty":-18.654427,"median":-10.382839,"eighty":-5.365218,"marketCap":2806128470},{"date":"2023-11-03","current":-4.68465,"twenty":-18.654427,"median":-10.364295,"eighty":-5.28414,"marketCap":2976073660},{"date":"2023-11-10","current":-4.517051,"twenty":-18.654427,"median":-10.342873,"eighty":-5.170628,"marketCap":2869601414},{"date":"2023-11-17","current":-5.034024,"twenty":-18.654427,"median":-10.305516,"eighty":-5.093229,"marketCap":3198025038},{"date":"2023-11-24","current":-5.058581,"twenty":-18.654427,"median":-10.281065,"eighty":-5.066839,"marketCap":3213625160},{"date":"2023-12-01","current":-5.0211,"twenty":-18.654427,"median":-10.19999,"eighty":-5.05703,"marketCap":3189814448},{"date":"2023-12-08","current":-5.353255,"twenty":-18.644324,"median":-10.171258,"eighty":-5.057805,"marketCap":3400826626},{"date":"2023-12-15","current":-5.933557,"twenty":-18.644324,"median":-10.119914,"eighty":-5.057805,"marketCap":3769482144},{"date":"2023-12-22","current":-5.885737,"twenty":-18.644324,"median":-10.02608,"eighty":-5.057805,"marketCap":3739102959},{"date":"2023-12-29","current":-6.238571,"twenty":-18.654427,"median":-9.99662,"eighty":-5.05703,"marketCap":3963252082},{"date":"2024-01-05","current":-6.086064,"twenty":-18.664531,"median":-9.939328,"eighty":-5.056254,"marketCap":3866367113},{"date":"2024-01-12","current":-5.964576,"twenty":-18.664531,"median":-9.900378,"eighty":-5.056254,"marketCap":3789187561},{"date":"2024-01-19","current":-5.578138,"twenty":-18.674634,"median":-9.811733,"eighty":-5.055479,"marketCap":3543690902},{"date":"2024-01-26","current":-5.848257,"twenty":-18.664531,"median":-9.7849,"eighty":-5.056254,"marketCap":3715292246},{"date":"2024-02-02","current":-5.699627,"twenty":-18.664531,"median":-9.642907,"eighty":-5.056254,"marketCap":3620870454},{"date":"2024-02-09","current":-5.874105,"twenty":-18.664531,"median":-9.594133,"eighty":-5.056254,"marketCap":3731713427},{"date":"2024-02-16","current":-6.261086,"twenty":-18.664531,"median":-9.561842,"eighty":-5.056254,"marketCap":3798219211},{"date":"2024-02-23","current":-6.634206,"twenty":-18.664531,"median":-9.488533,"eighty":-5.056254,"marketCap":4024568380},{"date":"2024-03-01","current":-7.019664,"twenty":-18.654427,"median":-9.448218,"eighty":-5.05703,"marketCap":4258401731},{"date":"2024-03-08","current":-6.901583,"twenty":-18.618504,"median":-9.331505,"eighty":-5.05703,"marketCap":4186769683},{"date":"2024-03-15","current":-6.331541,"twenty":-18.555722,"median":-9.248631,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-22","current":-6.331541,"twenty":-18.362305,"median":-9.119934,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-28","current":-6.354614,"twenty":-18.110177,"median":-9.054151,"eighty":-5.05703,"marketCap":3854956865},{"date":"2024-04-05","current":-6.389903,"twenty":-17.885675,"median":-8.975116,"eighty":-5.056254,"marketCap":3876364143},{"date":"2024-04-12","current":-6.881225,"twenty":-17.643907,"median":-8.928874,"eighty":-5.056254,"marketCap":4174419330},{"date":"2024-04-19","current":-5.887723,"twenty":-17.405641,"median":-8.865305,"eighty":-5.056254,"marketCap":3571722102},{"date":"2024-04-26","current":-5.951513,"twenty":-17.24545,"median":-8.784804,"eighty":-5.05703,"marketCap":3610419874},{"date":"2024-05-03","current":-5.85531,"twenty":-17.111877,"median":-8.730843,"eighty":-5.05703,"marketCap":3591360331},{"date":"2024-05-10","current":-5.582669,"twenty":-17.109146,"median":-8.602772,"eighty":-5.05703,"marketCap":3424135754},{"date":"2024-05-17","current":-5.770925,"twenty":-17.109146,"median":-8.502293,"eighty":-5.05703,"marketCap":3539602729},{"date":"2024-05-24","current":-5.403894,"twenty":-17.109146,"median":-8.437742,"eighty":-5.05703,"marketCap":3314483663},{"date":"2024-05-31","current":-5.234599,"twenty":-17.109146,"median":-8.326018,"eighty":-5.05703,"marketCap":3210646455},{"date":"2024-06-07","current":-5.657159,"twenty":-17.109146,"median":-8.22856,"eighty":-5.05703,"marketCap":3469824125},{"date":"2024-06-14","current":-6.362758,"twenty":-17.109548,"median":-8.139615,"eighty":-5.056254,"marketCap":3902604231},{"date":"2024-06-21","current":-5.610206,"twenty":-17.10995,"median":-8.062414,"eighty":-5.055479,"marketCap":3441025345},{"date":"2024-06-28","current":-6.111908,"twenty":-17.111877,"median":-7.980946,"eighty":-5.053152,"marketCap":3748744602},{"date":"2024-07-05","current":-5.933361,"twenty":-17.111877,"median":-7.91653,"eighty":-5.053152,"marketCap":3639232749},{"date":"2024-07-12","current":-6.476379,"twenty":-17.111877,"median":-7.842615,"eighty":-5.053152,"marketCap":3972293592},{"date":"2024-07-15","current":-6.660828,"twenty":-17.111877,"median":-7.815809,"eighty":-5.053152,"marketCap":4085425672},{"date":"2024-08-02","current":-6.829058,"twenty":-17.121885,"median":-7.700275,"eighty":-5.034024,"marketCap":3995825065},{"date":"2024-08-09","current":-7.915825,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4631715386},{"date":"2024-08-16","current":-8.142486,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4764339569},{"date":"2024-08-23","current":-8.871265,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5190763157},{"date":"2024-08-30","current":-8.965707,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5246023233},{"date":"2024-09-06","current":-8.885431,"twenty":-17.121885,"median":-7.70624,"eighty":-5.034024,"marketCap":5199052169},{"date":"2024-09-13","current":-9.102648,"twenty":-17.121885,"median":-7.774964,"eighty":-5.034024,"marketCap":5326150344},{"date":"2024-09-20","current":-9.252181,"twenty":-17.121885,"median":-7.849896,"eighty":-5.034024,"marketCap":5413645465},{"date":"2024-09-27","current":-8.691824,"twenty":-17.121885,"median":-7.916177,"eighty":-5.034024,"marketCap":5085769012},{"date":"2024-10-04","current":-8.446275,"twenty":-17.121885,"median":-7.994412,"eighty":-5.034024,"marketCap":4942092814},{"date":"2024-10-11","current":-8.47933,"twenty":-17.121885,"median":-8.063851,"eighty":-5.034024,"marketCap":4961433841},{"date":"2024-10-18","current":-8.9358,"twenty":-17.121885,"median":-8.144847,"eighty":-5.034024,"marketCap":5228524209},{"date":"2024-10-25","current":-8.628863,"twenty":-17.121885,"median":-8.21254,"eighty":-5.034024,"marketCap":5048928962},{"date":"2024-10-31","current":-8.1598,"twenty":-17.121885,"median":-8.258605,"eighty":-5.034024,"marketCap":4774470583},{"date":"2024-11-08","current":-8.324768,"twenty":-17.142899,"median":-8.319439,"eighty":-5.03169,"marketCap":4653445648},{"date":"2024-11-15","current":-7.864207,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395997435},{"date":"2024-11-22","current":-7.596785,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4246511376},{"date":"2024-11-29","current":-7.862556,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395074682},{"date":"2024-12-06","current":-7.814684,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4368314832},{"date":"2024-12-13","current":-7.7404,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4326790927},{"date":"2024-12-20","current":-7.175841,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4011209247},{"date":"2024-12-27","current":-7.233618,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4043505617},{"date":"2025-01-03","current":-6.792866,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":3797130446},{"date":"2025-01-10","current":-7.205555,"twenty":-17.163913,"median":-8.328682,"eighty":-5.029355,"marketCap":4027818809},{"date":"2025-01-17","current":-6.743343,"twenty":-17.163913,"median":-8.303187,"eighty":-5.029355,"marketCap":3769447843},{"date":"2025-01-24","current":-7.403646,"twenty":-17.163913,"median":-8.22856,"eighty":-5.029355,"marketCap":4138549223},{"date":"2025-01-31","current":-7.164286,"twenty":-17.163913,"median":-8.210902,"eighty":-5.029355,"marketCap":4004749973},{"date":"2025-02-07","current":-7.557166,"twenty":-17.163913,"median":-8.156652,"eighty":-5.029355,"marketCap":4224365294},{"date":"2025-02-14","current":-7.055416,"twenty":-17.163913,"median":-8.140574,"eighty":-5.029355,"marketCap":4015823014},{"date":"2025-02-21","current":-7.228695,"twenty":-17.163913,"median":-8.07435,"eighty":-5.029355,"marketCap":4114450084},{"date":"2025-02-28","current":-6.82078,"twenty":-17.163913,"median":-8.063851,"eighty":-5.029355,"marketCap":3882272258},{"date":"2025-03-07","current":-6.503875,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3701895062},{"date":"2025-03-14","current":-6.378738,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3630669195},{"date":"2025-03-21","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-03-28","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-04-04","current":-5.709174,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3249564556},{"date":"2025-04-11","current":-5.389018,"twenty":-17.163913,"median":-8.038932,"eighty":-5.047263,"marketCap":3067337338},{"date":"2025-04-17","current":-5.770746,"twenty":-17.163913,"median":-7.988725,"eighty":-5.047263,"marketCap":3284610351},{"date":"2025-04-25","current":-6.209573,"twenty":-17.184926,"median":-7.897222,"eighty":-5.047026,"marketCap":3534383465},{"date":"2025-05-02","current":-6.428987,"twenty":-17.184926,"median":-7.862556,"eighty":-5.047026,"marketCap":3659270022},{"date":"2025-05-09","current":-6.178877,"twenty":-17.184926,"median":-7.798177,"eighty":-5.047026,"marketCap":3395781282},{"date":"2025-05-16","current":-5.983104,"twenty":-17.184926,"median":-7.720227,"eighty":-5.047026,"marketCap":3288188434},{"date":"2025-05-23","current":-6.098164,"twenty":-17.184926,"median":-7.659513,"eighty":-5.047026,"marketCap":3351422827},{"date":"2025-05-30","current":-6.015733,"twenty":-17.184926,"median":-7.598263,"eighty":-5.047026,"marketCap":3306120575},{"date":"2025-06-06","current":-6.338587,"twenty":-17.184926,"median":-7.557166,"eighty":-5.047026,"marketCap":3483554394},{"date":"2025-06-13","current":-6.747307,"twenty":-17.184926,"median":-7.489485,"eighty":-5.047026,"marketCap":3708178059},{"date":"2025-06-20","current":-6.414149,"twenty":-17.20594,"median":-7.434667,"eighty":-5.04679,"marketCap":3525081458},{"date":"2025-06-27","current":-6.374651,"twenty":-17.20594,"median":-7.397868,"eighty":-5.04679,"marketCap":3503374129},{"date":"2025-07-03","current":-6.85378,"twenty":-17.20594,"median":-7.331032,"eighty":-5.04679,"marketCap":3766693467},{"date":"2025-07-11","current":-5.329668,"twenty":-17.20594,"median":-7.284263,"eighty":-5.04679,"marketCap":2929073710},{"date":"2025-07-18","current":-4.707144,"twenty":-17.20594,"median":-7.231156,"eighty":-5.019717,"marketCap":2586947330},{"date":"2025-07-25","current":-4.688253,"twenty":-17.20594,"median":-7.2205,"eighty":-4.990742,"marketCap":2576565564},{"date":"2025-08-01","current":-4.691688,"twenty":-17.20594,"median":-7.178045,"eighty":-4.933118,"marketCap":2578453158},{"date":"2025-08-08","current":-5.023544,"twenty":-17.20594,"median":-7.165937,"eighty":-4.922401,"marketCap":2677207288},{"date":"2025-08-15","current":-5.236544,"twenty":-17.120341,"median":-7.127226,"eighty":-4.922401,"marketCap":2790721647},{"date":"2025-08-22","current":-5.328603,"twenty":-16.992353,"median":-7.100943,"eighty":-4.922401,"marketCap":2839782937},{"date":"2025-08-29","current":-5.469399,"twenty":-16.931942,"median":-7.088351,"eighty":-4.922401,"marketCap":2914817852},{"date":"2025-09-05","current":-5.646297,"twenty":-16.867084,"median":-7.050962,"eighty":-4.921583,"marketCap":3009092489},{"date":"2025-09-12","current":-5.637272,"twenty":-16.862117,"median":-7.009732,"eighty":-4.922401,"marketCap":3004282559},{"date":"2025-09-19","current":-5.254594,"twenty":-16.862117,"median":-6.97646,"eighty":-4.922401,"marketCap":2800341507},{"date":"2025-09-26","current":-5.021739,"twenty":-16.862117,"median":-6.933137,"eighty":-4.922401,"marketCap":2676245302},{"date":"2025-10-03","current":-5.577704,"twenty":-16.789633,"median":-6.862153,"eighty":-4.922401,"marketCap":2972537018},{"date":"2025-10-10","current":-5.71489,"twenty":-16.494533,"median":-6.851457,"eighty":-4.922401,"marketCap":3045647960},{"date":"2025-10-17","current":-6.131864,"twenty":-16.395701,"median":-6.820464,"eighty":-4.922401,"marketCap":3267866747},{"date":"2025-10-24","current":-6.070492,"twenty":-16.196687,"median":-6.815304,"eighty":-4.922401,"marketCap":3235159220},{"date":"2025-10-31","current":-6.348474,"twenty":-16.144099,"median":-6.798969,"eighty":-4.922401,"marketCap":3383305078}],"updateTime":1762139750104},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RARE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566069682","title":"Ultragenyx Pharma Price Target Maintained With a $80.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2566069682","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566069682?lang=en_us&edition=fundamental","pubTime":"2025-09-09 18:26","pubTimestamp":1757413560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RARE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 09, 2025 06:26 ET (10:26 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"2566376016","title":"Ultragenyx Pharmaceutical Reports Positive Phase 3 Data on Rare Metabolic Disorder Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2566376016","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566376016?lang=en_us&edition=fundamental","pubTime":"2025-09-09 05:02","pubTimestamp":1757365347,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical  reported positive longer-term results from its Phase 3 study of a gene therapy developed to treat glycogen storage disease type Ia, a rare and life-threatening metabolic disorder.The investigational therapy DTX401 led to further reductions in patients' reliance on cornstarch supplements at week 96, while maintaining stable blood sugar levels and improving fasting tolerance, the company said Monday in a statement.\"These results are consistent with the positive data observed in the Phase 1/2 study and underscore the robustness and progressive improvement of treatment effect that can potentially be achieved with this gene therapy,\" Chief Medical Officer Eric Crombez said in the statement.The gene therapy was well tolerated with an acceptable safety profile, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2566634256","title":"Ultragenyx Announces Promising Phase 3 Results for DTX401 Gene Therapy in Treating Glycogen Storage Disease Type Ia","url":"https://stock-news.laohu8.com/highlight/detail?id=2566634256","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566634256?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:05","pubTimestamp":1757361949,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc. has announced positive longer-term results from its Phase 3 study of DTX401, an AAV gene therapy for the treatment of glycogen storage disease type Ia . The data, presented at the International Congress of Inborn Errors of Metabolism  2025 in Kyoto, Japan, demonstrated that at Week 96, participants experienced greater reductions in daily cornstarch intake while maintaining low levels of hypoglycemia, improved euglycemia, and enhanced fasting tolerance. The therapy was well tolerated with an acceptable safety profile. Additionally, 83% of the DTX401 group and 95% of the crossover group reported improvements in disease burden, as indicated by the Patient Global Impression of Change. These findings underscore the potential of DTX401 in reducing disease burden and decreasing the risk of severe hypoglycemia among patients with GSDIa.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL74C1Cr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","BK4588","RARE","IE00B3QW5Z07.USD","BK4112","LU2095319765.USD","IE00B64PRP62.GBP","LU2210150020.SGD","NDAQ","LU0314104364.USD","LU2210149790.SGD","BK4585","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2566634485","title":"Ultragenyx Announces Positive Longer-Term Data From Phase 3 Study of Dtx401 Aav Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (Gsdia)","url":"https://stock-news.laohu8.com/highlight/detail?id=2566634485","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566634485?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:05","pubTimestamp":1757361900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUABNZZDH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2566634292","title":"Ultragenyx Pharmaceutical Inc - Dtx401 Was Well Tolerated With an Acceptable Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2566634292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566634292?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:05","pubTimestamp":1757361900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUABNZZDH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2566216634","title":"Ultragenyx Pharmaceutical Inc - Study Met Primary Endpoint With 41% Cornstarch Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2566216634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566216634?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:05","pubTimestamp":1757361900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUABNZZDH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2566636786","title":"Ultragenyx SVP Theodore Huizenga Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2566636786","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566636786?lang=en_us&edition=fundamental","pubTime":"2025-09-09 02:02","pubTimestamp":1757354541,"startTime":"0","endTime":"0","summary":"Theodore Alan Huizenga, SVP and Chief Accounting Officer, reported a disposal of common shares of Ultragenyx Pharmaceutical Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL8vsQ39:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2565566522","title":"Ultragenyx Pharma Price Target Maintained With a $105.00/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2565566522","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565566522?lang=en_us&edition=fundamental","pubTime":"2025-09-05 21:54","pubTimestamp":1757080440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RARE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 05, 2025 09:54 ET (13:54 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"2563074662","title":"Ultragenyx Pharmaceutical Inc. to Participate in Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2563074662","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563074662?lang=en_us&edition=fundamental","pubTime":"2025-08-30 04:30","pubTimestamp":1756499423,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc. will participate in the Cantor Global Healthcare Conference 2025 in New York, NY, on Thursday, September 4, 2025. Eric Crombez, M.D., Chief Medical Officer, and Howard Horn, Chief Financial Officer, will engage in a fireside chat and host one-on-one meetings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire  on August 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL5rNGbj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","NDAQ","IE00BKPKM429.USD","RARE","BK4585","LU2210150020.SGD","LU0314104364.USD","LU2095319765.USD","BK4588","BK4139","LU2210149790.SGD","BK4112"],"gpt_icon":0},{"id":"2561116204","title":"BRIEF-Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2561116204","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561116204?lang=en_us&edition=fundamental","pubTime":"2025-08-22 05:41","pubTimestamp":1755812492,"startTime":"0","endTime":"0","summary":"BRIEF-Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)Aug 21 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:ULTRAGENYX REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA8W2TNH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2561419691","title":"Ultragenyx Pharmaceutical Announces Grant of 113,572 Restricted Stock Units to New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2561419691","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561419691?lang=en_us&edition=fundamental","pubTime":"2025-08-22 05:00","pubTimestamp":1755810013,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc., a biopharmaceutical company specializing in therapies for rare and ultra-rare diseases, has announced the grant of 113,572 restricted stock units to 33 newly hired non-executive officers. These stock units will vest over four years, with 25% becoming available on each anniversary of the grant date, provided the employees remain with the company. This initiative forms part of Ultragenyx's efforts to enhance its workforce and support the company's growth in the biopharmaceutical sector.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire  on August 21, 2025, and is solely responsible for the informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL8h6HTB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4585","NDAQ","LU0314104364.USD","IE00B64PRP62.GBP","BK4112","RARE","LU2210149790.SGD","BK4139","LU2210150020.SGD","BK4588"],"gpt_icon":0},{"id":"2560902641","title":"Ultragenyx Initiates Rolling Submission of BLA to FDA for DTX401 Gene Therapy for Glycogen Storage Disease Type Ia","url":"https://stock-news.laohu8.com/highlight/detail?id=2560902641","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560902641?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:00","pubTimestamp":1755518415,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc. has initiated a rolling submission of a Biologics License Application  to the U.S. Food and Drug Administration  for DTX401, an AAV gene therapy aimed at treating Glycogen Storage Disease Type Ia . The company plans to complete the full BLA submission, including the chemistry, manufacturing, and controls module, by the fourth quarter of 2025. This rolling submission allows the FDA to begin reviewing the non-clinical and clinical sections of the BLA while Ultragenyx addresses any questions related to manufacturing and facility compliance. The submission includes data from a Phase 3 study showing significant reductions in patients' cornstarch requirements, a current treatment necessity for managing hypoglycemia in GSDIa patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nNDLbpzdMp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BGHQF748.EUR","LU0314104364.USD","BK4139","IE00B3QW5Z07.USD","BK4588","IE00B64PRP62.GBP","LU2095319765.USD","BK4585","RARE","NDAQ","IE00BKPKM429.USD","LU2210150020.SGD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2560990299","title":"Ultragenyx Pharmaceutical Inc - Plans to Complete Full Bla Submission in Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2560990299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560990299?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:00","pubTimestamp":1755518402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nTUA6DXVLH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2560490259","title":"Ultragenyx Initiates Rolling Submission of Biologics License Application (Bla) to U.S. FDA for Dtx401 Aav Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (Gsdia)","url":"https://stock-news.laohu8.com/highlight/detail?id=2560490259","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560490259?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:00","pubTimestamp":1755518402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nTUA6DXVLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2558570476","title":"Ultragenyx Pharma Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2558570476","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558570476?lang=en_us&edition=fundamental","pubTime":"2025-08-09 05:46","pubTimestamp":1754689560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RARE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 08, 2025 17:46 ET (21:46 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"1169361390","title":"Stock Track | Ultragenyx Pharmaceutical Plummets 5% as Leerink Partners Slashes Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1169361390","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169361390?lang=en_us&edition=fundamental","pubTime":"2025-08-06 22:31","pubTimestamp":1754490696,"startTime":"0","endTime":"0","summary":"Shares of Ultragenyx Pharmaceutical (RARE) plunged 5.05% in Wednesday's trading session, following a significant downward revision in its price target by Leerink Partners. The biotechnology company,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["RARE"],"gpt_icon":0},{"id":"2557314150","title":"Earnings Flash: (RARE) Ultragenyx Pharmaceutical Q2 Revenue $166.5 million Vs. FactSet Est. $162 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557314150","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557314150?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:42","pubTimestamp":1754426560,"startTime":"0","endTime":"0","summary":"Earnings Flash: (RARE) Ultragenyx Pharmaceutical Q2 Revenue $166.5 million Vs. FactSet Est. $162 Million","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RARE"],"gpt_icon":0},{"id":"2557331925","title":"Ultragenyx Reports Q2 2025 Results: Revenue Up 20%, Net Loss Narrows to $115M, EPS Improves to $(1.17)","url":"https://stock-news.laohu8.com/highlight/detail?id=2557331925","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557331925?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:02","pubTimestamp":1754424121,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc. reported its financial results for the second quarter of 2025, highlighting a total revenue of $166 million. This reflects a continuation of the company's growth trajectory, with notable contributions from Crysvita and Dojolvi, which generated revenues of $120 million and $23 million, respectively. The company recorded a net loss of $115 million for the quarter, an improvement compared to a net loss of $132 million in the same period of 2024. Ultragenyx's revenue guidance for the full year 2025 remains unchanged, with expectations of total revenue between $640 million and $670 million. The company anticipates Crysvita revenue to be between $460 million and $480 million, and Dojolvi revenue to fall between $90 million and $100 million. Ultragenyx continues to advance its pipeline, with significant developments including the Phase 3 data from UX143 for osteogenesis imperfecta expected by the end of the year. Additionally, GTX-102 for Angelman syndrome has r","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL35hGbF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","RARE"],"gpt_icon":0},{"id":"2557319190","title":"Ultragenyx Pharmaceutical Q2 EPS $(1.17) Beats $(1.32) Estimate, Sales $166.50M Beat $162.50M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557319190","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557319190?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:01","pubTimestamp":1754424117,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical (NASDAQ:RARE) reported quarterly losses of $(1.17) per share which beat the analyst consensus estimate of $(1.32) by 11.36 percent. This is a 23.03 percent increase over losses of $(1.52) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46870806/ultragenyx-pharmaceutical-q2-eps-1-17-beats-1-32-estimate-sales-166-50m-beat-162-50m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ultragenyx Pharmaceutical Q2 EPS $(1.17) Beats $(1.32) Estimate, Sales $166.50M Beat $162.50M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"2557194423","title":"BRIEF-Ultragenyx Q2 EPS USD -1.17","url":"https://stock-news.laohu8.com/highlight/detail?id=2557194423","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557194423?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:01","pubTimestamp":1754424108,"startTime":"0","endTime":"0","summary":"BRIEF-Ultragenyx Q2 EPS USD -1.17\n\n\nAug 05 (Reuters) - Ultragenyx Q2 operating expenses USD 274 million.\n\nQ2 net income USD -115 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nPLX6D6EEB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":84,"code":"91000000","status":"200"}]}}